These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1057932)

  • 21. Single-dose pharmacokinetics of cefpirome in patients with renal impairment.
    Lameire N; Malerczyk V; Drees B; Lehr K; Rosenkranz B
    Clin Pharmacol Ther; 1992 Jul; 52(1):24-30. PubMed ID: 1623690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis.
    Brody SR; Humphreys MH; Gambertoglio JG; Schoenfeld P; Cundy KC; Aweeka FT
    Clin Pharmacol Ther; 1999 Jan; 65(1):21-8. PubMed ID: 9951427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and safety of iomeprol in healthy volunteers and in patients with renal impairment or end-stage renal disease requiring hemodialysis.
    Lorusso V; Taroni P; Alvino S; Spinazzi A
    Invest Radiol; 2001 Jun; 36(6):309-16. PubMed ID: 11410750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of renal impairment and haemodialysis on single dose pharmacokinetics of oral enoxacin.
    Nix DE; Schultz RW; Frost RW; Sedman AJ; Thomas DJ; Kinkel AW; Schentag JJ
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():87-95. PubMed ID: 3162906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Odour perception in chronic renal disease.
    Griep MI; Van der Niepen P; Sennesael JJ; Mets TF; Massart DL; Verbeelen DL
    Nephrol Dial Transplant; 1997 Oct; 12(10):2093-8. PubMed ID: 9351071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erythromycin and clindamycin absorption and elimination in pregnant women.
    Philipson A; Sabath LD; Charles D
    Clin Pharmacol Ther; 1976 Jan; 19(1):68-77. PubMed ID: 1245094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical pharmacological studies with the vasodilator endralazine in patients with renal impairment.
    Elliott HL; Meredith PA; Sloan L; Reid JL
    Eur J Clin Pharmacol; 1984; 27(2):159-63. PubMed ID: 6499896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of flupirtine in elderly volunteers and in patients with moderate renal impairment.
    Abrams SM; Baker LR; Crome P; White AS; Johnston A; Ankier SI; Warrington SJ; Turner P; Niebch G
    Postgrad Med J; 1988 May; 64(751):361-3. PubMed ID: 3200777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of ornidazole in patients with renal insufficiency; influence of haemodialysis and peritoneal dialysis.
    Merdjan H; Baumelou A; Diquet B; Chick O; Singlas E
    Br J Clin Pharmacol; 1985 Feb; 19(2):211-7. PubMed ID: 3986079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An overview of the pharmacology of intravenously administered ciprofloxacin.
    Drusano GL
    Am J Med; 1987 Apr; 82(4A):339-45. PubMed ID: 3578325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of amoxicillin in subjects with normal and impaired renal function.
    Arancibia A; Drouguett MT; Fuentes G; González G; González C; Thambo S; Palombo G
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):447-53. PubMed ID: 7141752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of intravenously administered tobramycin in normal volunteers and in renal-impaired and hemodialyzed patients.
    Péchère JC; Dugal R
    J Infect Dis; 1976 Aug; 134 Suppl():S118-24. PubMed ID: 972269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-dose pharmacokinetics of lomefloxacin in patients with normal and impaired renal function.
    Nilsen OG; Saltvedt E; Walstad RA; Marstein S
    Am J Med; 1992 Apr; 92(4A):38S-40S. PubMed ID: 1316068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of sulpiride after intravenous administration in patients with impaired renal function.
    Bressolle F; Brès J; Mourad G
    Clin Pharmacokinet; 1989 Nov; 17(5):367-73. PubMed ID: 2582694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elimination kinetics of mezlocillin in normal and impaired renal function including the effects of dialysis.
    Kosmidis J; Doundoulaki P; Stathakis C; Zerefos N; Bounia A; Daikos GK
    Arzneimittelforschung; 1979; 29(12a):1960-2. PubMed ID: 543901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of ofloxacin in healthy subjects and patients with varying degrees of renal impairment.
    Flor S; Guay D; Opsahl J; Tack K; Matzke G
    Int J Clin Pharmacol Res; 1991; 11(3):115-21. PubMed ID: 1809697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of renal impairment on the pharmacokinetics of levomilnacipran following a single oral dose of levomilnacipran extended-release capsule in humans.
    Chen L; Greenberg WM; Brand-Schieber E; Wangsa J; Periclou A; Ghahramani P
    Drug Des Devel Ther; 2015; 9():3293-300. PubMed ID: 26150701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and safety of the ketolide telithromycin in patients with renal impairment.
    Shi J; Montay G; Chapel S; Hardy P; Barrett JS; Sack M; Marbury T; Swan SK; Vargas R; Leclerc V; Leroy B; Bhargava VO
    J Clin Pharmacol; 2004 Mar; 44(3):234-44. PubMed ID: 14973302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of repaglinide in subjects with renal impairment.
    Marbury TC; Ruckle JL; Hatorp V; Andersen MP; Nielsen KK; Huang WC; Strange P
    Clin Pharmacol Ther; 2000 Jan; 67(1):7-15. PubMed ID: 10668848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinetics of cefsulodin in patients with renal impairment.
    Gibson TP; Granneman GR; Kallal JE; Sennello LT
    Rev Infect Dis; 1984; 6 Suppl 3():S689-97. PubMed ID: 6571338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.